Reply: To PMID 25105313

Affiliations

¹ *Department of Ophthalmology, Tongliao City Hospital, Tongliao, China †State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China ‡The Royal Victorian Eye and Ear Hospital, Melbourne, Australia §Department of Ophthalmology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China ¶Department of Ophthalmology, The First Affiliated Hospital of Kunming Medical University, Kunming, China **Aier School of Ophthalmology, Central South University, Changsha, China.

Comment

Qingyun Liu et al. Retina. 2015 Nov.

. 2015 Nov;35(11):e69-70.

doi: 10.1097/IAE.0000000000000791.

¹ *Department of Ophthalmology, Tongliao City Hospital, Tongliao, China †State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China ‡The Royal Victorian Eye and Ear Hospital, Melbourne, Australia §Department of Ophthalmology, General Hospital of Guangzhou Military Command of PLA, Guangzhou, China ¶Department of Ophthalmology, The First Affiliated Hospital of Kunming Medical University, Kunming, China **Aier School of Ophthalmology, Central South University, Changsha, China.

No abstract available

Comment on

Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q, Hu Y, Yu H, Yuan L, Hu J, Atik A, Guan M, Li D, Li X, Tang S. Liu Q, et al. Retina. 2015 Feb;35(2):272-9. doi: 10.1097/IAE.0000000000000300. Retina. 2015. PMID: 25105313
Correspondence.
Venkatesh R, Jhala PA, Agarwal M, Singh S, Mayor R, Paul L. Venkatesh R, et al. Retina. 2015 Nov;35(11):e69. doi: 10.1097/IAE.0000000000000790. Retina. 2015. PMID: 26441268 No abstract available.